Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT A REISS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1588746150
CMS profile
1205624
Location
ROLLING HILLS ESTATES, CA

General Payments · PY2018–2024

$1,079.54

  • Reported across 33 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$399.49

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $399.49 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $325.54 12
INTRA-SANA LABORATORIES $50.00 1
OPKO Pharmaceuticals, LLC $23.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $445.08 13
PY2019 $95.62 4
PY2022 $17.50 1
PY2023 $121.85 1
PY2024 $399.49 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Intra-Sana Laboratories $50.00 10/15/2024 Food and Beverage Undisputed 01/23/2026 1138619758 CMS
Novartis Pharmaceuticals Corporation $13.32 03/07/2024 Food and Beverage Undisputed 01/23/2026 1087323167 CMS
Novartis Pharmaceuticals Corporation $29.88 03/07/2024 Food and Beverage Undisputed 01/23/2026 1087323169 CMS
Novartis Pharmaceuticals Corporation $32.84 05/30/2024 Food and Beverage Undisputed 01/23/2026 1087323175 CMS
Novartis Pharmaceuticals Corporation $41.48 08/22/2024 Food and Beverage Undisputed 01/23/2026 1087323199 CMS
Novartis Pharmaceuticals Corporation $13.99 08/22/2024 Food and Beverage Undisputed 01/23/2026 1087323201 CMS
Novartis Pharmaceuticals Corporation $34.20 09/05/2024 Food and Beverage Undisputed 01/23/2026 1087323195 CMS
Novartis Pharmaceuticals Corporation $29.90 09/09/2024 Food and Beverage Undisputed 01/23/2026 1087323197 CMS
Novartis Pharmaceuticals Corporation $10.58 10/17/2024 Food and Beverage Undisputed 01/23/2026 1087323203 CMS
Novartis Pharmaceuticals Corporation $28.30 11/05/2024 Food and Beverage Undisputed 01/23/2026 1087323205 CMS
Novartis Pharmaceuticals Corporation $42.89 11/14/2024 Food and Beverage Undisputed 01/23/2026 1087323207 CMS
Novartis Pharmaceuticals Corporation $38.49 11/21/2024 Food and Beverage Undisputed 01/23/2026 1087323227 CMS
Novartis Pharmaceuticals Corporation $9.67 11/21/2024 Food and Beverage Undisputed 01/23/2026 1087323229 CMS
OPKO Pharmaceuticals, LLC $23.95 03/28/2024 Food and Beverage Undisputed 01/23/2026 1112848920 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.